Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration

The retina is part of the central nervous system, its analysis may provide an idea of the health and functionality, not only of the retina, but also of the entire central nervous system, as has been shown in Alzheimer’s or Parkinson’s diseases. Within the retina, the ganglion cells (RGC) are the neu...

Full description

Bibliographic Details
Main Authors: Ciriaco Corral-Domenge, Pedro de la Villa, Alicia Mansilla, Francisco Germain
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/8/4287
_version_ 1797434556657172480
author Ciriaco Corral-Domenge
Pedro de la Villa
Alicia Mansilla
Francisco Germain
author_facet Ciriaco Corral-Domenge
Pedro de la Villa
Alicia Mansilla
Francisco Germain
author_sort Ciriaco Corral-Domenge
collection DOAJ
description The retina is part of the central nervous system, its analysis may provide an idea of the health and functionality, not only of the retina, but also of the entire central nervous system, as has been shown in Alzheimer’s or Parkinson’s diseases. Within the retina, the ganglion cells (RGC) are the neurons in charge of processing and sending light information to higher brain centers. Diverse insults and pathological states cause degeneration of RGC, leading to irreversible blindness or impaired vision. RGCs are the measurable endpoints in current research into experimental therapies and diagnosis in multiple ocular pathologies, like glaucoma. RGC subtype classifications are based on morphological, functional, genetical, and immunohistochemical aspects. Although great efforts are being made, there is still no classification accepted by consensus. Moreover, it has been observed that each RGC subtype has a different susceptibility to injury. Characterizing these subtypes together with cell death pathway identification will help to understand the degenerative process in the different injury and pathological models, and therefore prevent it. Here we review the known RGC subtypes, as well as the diagnostic techniques, probes, and biomarkers for programmed and unprogrammed cell death in RGC.
first_indexed 2024-03-09T10:34:00Z
format Article
id doaj.art-5416098b29a14f1eb524a4fc2c1b8349
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T10:34:00Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-5416098b29a14f1eb524a4fc2c1b83492023-12-01T21:03:46ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01238428710.3390/ijms23084287Tools and Biomarkers for the Study of Retinal Ganglion Cell DegenerationCiriaco Corral-Domenge0Pedro de la Villa1Alicia Mansilla2Francisco Germain3Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, SpainInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, SpainInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, SpainInstituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28034 Madrid, SpainThe retina is part of the central nervous system, its analysis may provide an idea of the health and functionality, not only of the retina, but also of the entire central nervous system, as has been shown in Alzheimer’s or Parkinson’s diseases. Within the retina, the ganglion cells (RGC) are the neurons in charge of processing and sending light information to higher brain centers. Diverse insults and pathological states cause degeneration of RGC, leading to irreversible blindness or impaired vision. RGCs are the measurable endpoints in current research into experimental therapies and diagnosis in multiple ocular pathologies, like glaucoma. RGC subtype classifications are based on morphological, functional, genetical, and immunohistochemical aspects. Although great efforts are being made, there is still no classification accepted by consensus. Moreover, it has been observed that each RGC subtype has a different susceptibility to injury. Characterizing these subtypes together with cell death pathway identification will help to understand the degenerative process in the different injury and pathological models, and therefore prevent it. Here we review the known RGC subtypes, as well as the diagnostic techniques, probes, and biomarkers for programmed and unprogrammed cell death in RGC.https://www.mdpi.com/1422-0067/23/8/4287retinal ganglion cellsneurodegenerationmarkersapoptosisglaucoma
spellingShingle Ciriaco Corral-Domenge
Pedro de la Villa
Alicia Mansilla
Francisco Germain
Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration
International Journal of Molecular Sciences
retinal ganglion cells
neurodegeneration
markers
apoptosis
glaucoma
title Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration
title_full Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration
title_fullStr Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration
title_full_unstemmed Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration
title_short Tools and Biomarkers for the Study of Retinal Ganglion Cell Degeneration
title_sort tools and biomarkers for the study of retinal ganglion cell degeneration
topic retinal ganglion cells
neurodegeneration
markers
apoptosis
glaucoma
url https://www.mdpi.com/1422-0067/23/8/4287
work_keys_str_mv AT ciriacocorraldomenge toolsandbiomarkersforthestudyofretinalganglioncelldegeneration
AT pedrodelavilla toolsandbiomarkersforthestudyofretinalganglioncelldegeneration
AT aliciamansilla toolsandbiomarkersforthestudyofretinalganglioncelldegeneration
AT franciscogermain toolsandbiomarkersforthestudyofretinalganglioncelldegeneration